Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction

Mingwei Guo(Jinan University), Xinran Ma(Zhengzhou People's Hospital), Lingyan Xu(East China Normal University), Jian Lü(Sun Yat-sen University), Cheng Hu(Shanghai Jiao Tong University), Yinzhao Zhong(East China Normal University), Shuzhe Ding(East China Normal University), Jin Li(Peking University), Yi Zhang(Huazhong University of Science and Technology), Jun Zhang(Chinese Academy of Agricultural Sciences), Bo Xu(Rutgers New Jersey Medical School), Jing Yao(China Pharmaceutical University), Fei Shen(Changchun University of Science and Technology), Hui Zuo(East China Normal University), Dongmei Wang(Hengshui University), Junjie Xiao(Shanghai University)
Journal of Cachexia Sarcopenia and Muscle
December 12, 2022
10.1002/jcsm.13141
Cited by 156

Related Papers

Circular RNAs: Promising Biomarkers for Human Diseases
|EBioMedicine|2018|823
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
|Cell|2016|376
Biomarkers of aging
|Science China Life Sciences|2023|362
The effect of economic growth target constraints on green technology innovation
|Journal of Environmental Management|2021|347
Large-scale genome-wide association studies in east Asians identify new genetic loci influencing metabolic traits
|Nature Genetics|2011|296